The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Blinded by the Light: The Growing Complexity of p53
Open accessAbstract
While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transient stress leads to induction of p53 which activates DNA repair and leads to quiescence (Vousden and Prives, 2009; Kasteri et al., 2018).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Vousden and Prives, 2009
In the citing paper
“Consequently, p53 target genes become activated and drive cellular responses of tumor cells, which include cell cycle arrest, apoptosis and senescence. 2”
From Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death (2013) · cites this paper as [2]
In the citing paper
“p53 is a key transcriptional regulator that controls multiple signals by activating genes with roles in cell cycle arrest, senescence, apoptosis, metabolism, differentiation, and survival (Vousden and Prives, 2009).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Vousden and Prives, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–231 of 231
Cellular senescence bypass screen identifies new putative tumor suppressor genes
Martínez-Leal, J. F., Fominaya, J. M., Cascón, A., Guijarro, M. V., Blanco‐Aparicio, C., LLeonart, M. E., Castro, M. E., y Cajal, S. R., Robledo, M., Beach, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210846 · Cited by 64
Cell cycle‐dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315
Fogal, V., Hsieh, J.-K., Royer, C., Zhong, S., & Lü, X. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600735 · Cited by 64
Multivalent Binding of p53 to the STAGA Complex Mediates Coactivator Recruitment after UV Damage
Gamper, A. M., & Roeder, R. G. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01461-07 · Cited by 64
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
París, R., Henry, R. E., Stephens, S. J., McBryde, M., & Espinosa, J. M. (2008) · Cell Cycle · doi:10.4161/cc.6420 · Cited by 62
Baptiste-Okoh, N., Barsotti, A. M., & Prives, C. L. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5805 · Cited by 61
Self-citationHearnes, J. M., Mays, D. J., Schavolt, K. L., Tang, L., Jiang, X. J., & Pietenpol, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10148-10158.2005 · Cited by 57
MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation
Jin, Y., Zeng, S. X., Lee, H., & Lu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309916200 · Cited by 56
Liu, P., Xu, B., Cavalieri, T. A., & Hock, C. E. (2006) · Shock · doi:10.1097/01.shk.0000232273.11225.af · Cited by 56
Batta, K., & Kundu, T. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01064-07 · Cited by 55
Unfolded p53: A Potential Biomarker for Alzheimer's Disease
Lanni, C., Uberti, D. L., Racchi, M., Govoni, S. M., & Memo, M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12109 · Cited by 54
Augustyn, K. E., Merino, E. J., & Barton, J. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709326104 · Cited by 54
Zhan, M., Yu, D., Liu, J., Hannay, J. A. F., & Pollock, R. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407450200 · Cited by 52
Mutational Analysis of the p53 Core Domain L1 Loop
Zupnick, A., & Prives, C. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603387200 · Cited by 51
Self-citationMatsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47
Ohkubo, S., Tanaka, T., Taya, Y., Kitazato, K., & Prives, C. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601388200 · Cited by 47
Self-citationOf flies and men; p53, a tumour suppressor
Sutcliffe, J. E., & Brehm, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.122 · Cited by 46
Wilkinson, D. S., Tsai, W.-W., Schumacher, M. A., & Barton, M. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01442-07 · Cited by 45
A review of contusugene ladenovec (Advexin) p53 therapy.
Senzer, N. N., & Nemunaitis, J. J. (2009) · PubMed · Cited by 44
Dobzhansky, T. (1967) · American Psychologist · doi:10.1037/h0024286 · Cited by 39
Budhram-Mahadeo, V. S., Bowen, S., Lee, S., Perez-Sanchez, C., Ensor, E. A., Morris, P. J., & Latchman, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl878 · Cited by 38
Shmueli, A., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.006 · Cited by 37
White, D. E., Talbott, K. E., Arva, N. C., & Bargonetti, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1381 · Cited by 36
Reassessing the role of p53 in cancer and ageing from an evolutionary perspective
Aranda-Anzaldo, A., & Dent, M. A. R. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.01.001 · Cited by 36
Bruins, W., Bruning, O., Jonker, M. J., Zwart, E., van der Hoeven, T. V., Pennings, J. L. A., Rauwerda, H., de Vries, A., & Breit, T. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01610-07 · Cited by 35
Ser58 of mouse p53 is the homologue of human Ser46 and is phosphorylated by HIPK2 in apoptosis
Cecchinelli, B., Porrello, A., Lazzari, C., Gradi, A., Bossi, G., D'Angelo, M., Sacchi, A., & Soddu, S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401933 · Cited by 31
p53-Induced DNA Bending: The Interplay between p53−DNA and p53−p53 Interactions
Pan, Y., & Nussinov, R. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp800680w · Cited by 31
Rother, K., Li, Y., Tschöp, K., Kirschner, R. D., Müller, G. A., Mössner, J., & Engeland, K. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4017 · Cited by 28
p53 Regulation Orchestrates the TGF-β Response
Piccolo, S. (2008) · Cell · doi:10.1016/j.cell.2008.05.013 · Cited by 27
Insights into Selective Activation of p53 DNA Binding by c-Abl
Wei, G., Li, A. G., & Liu, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409522200 · Cited by 22
Bruins, W., Jonker, M. J., Bruning, O., Pennings, J. L. A., Schaap, M. M., Hoogervorst, E. M., STEEG, H. V., Breit, T. M., & de Vries, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm041 · Cited by 13
Berns, A. J. M. (2006) · Nature · doi:10.1038/443153a · Cited by 12
Flagged first, then by citations
1 of the 232 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2020) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,640
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
“Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. p21 and PAI-1, both regulated by p53, are implicated in protection of cancer and other cell types from apoptosis (Gartel & Radhakrishnan, 2005; Kortlever et al., 2006; Schneider et al., 2008; Vousden & Prives, 2009).”
BackgroundIntrinsically disordered proteins in cellular signalling and regulation
Wright, P. E., & Dyson, H. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3920 · Cited by 2,482
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Programmed Cell Death in Animal Development and Disease
Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915
Metadata
- Authors
- Vousden, K. H., & Prives, C.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Columbia University (US)
- Corresponding author
- Vousden, Karen H.
- Prives, Carol
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 137
- Issue
- 3
- Pages
- 413-431
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2133959309
- Semantic Scholar
- 018e8ed8c8694d45cfd9ffaf967368345fe22af6
- Cited by
- 3,163
- References
- 232
- Citations by year
- 2026: 128 · 2025: 154 · 2024: 127 · 2023: 168 · 2022: 149 · 2021: 166 · 2020: 175 · 2019: 149 · 2018: 171 · 2017: 191 · 2016: 228 · 2015: 202 · 2014: 258 · 2013: 263 · 2012: 228
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1538 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK
- National Cancer Institute (R01CA077742, CA77742)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, tumor suppressor, transcriptional activation, p53 activators, p53 inhibitors, p53 regulation
- MeSH terms
- Animals, Cell Survival, Cell Transformation, Neoplastic, Gene Expression Regulation, Humans, Mutation, Stress, Physiological, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
